These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 294133)

  • 1. Blood levels and side-effects of D-penicillamine.
    Van Der Korst JK; Muijsers AO; Henrichs AM; Ament HJ; Van De Stadt RJ
    Agents Actions Suppl; 1979; (5):159-67. PubMed ID: 294133
    [No Abstract]   [Full Text] [Related]  

  • 2. Penicillamine metal chelates and their possible importance in rheumatoid arthritis--a brief review.
    Davis P
    Clin Invest Med; 1984; 7(1):41-4. PubMed ID: 6723123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis.
    Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M
    Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences in the treatment of chronic polyarthritis using D-penicillamine (proceedings)].
    Dürrigl T; Pucar I
    Z Rheumatol; 1976; 35 Suppl 4():suppl 464-9. PubMed ID: 983407
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
    Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ
    J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis.
    Matthey F; Perrett D; Greenwood RN; Baker LR
    Clin Nephrol; 1986 May; 25(5):268-71. PubMed ID: 3720037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of penicillamine on the blood serum copper level and acute phase tests in patients with rheumatoid arthritis].
    Rudy J; Sarosiek J
    Reumatologia; 1978; 16(2):237-44. PubMed ID: 694258
    [No Abstract]   [Full Text] [Related]  

  • 8. D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects.
    Muijsers AO; van de Stadt RJ; Henrichs AM; Ament HJ; van der Korst JK
    Arthritis Rheum; 1984 Dec; 27(12):1362-9. PubMed ID: 6508861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The serum copper level and the therapeutic effect of D-penicylamine in patients with rheumatoid arthritis (author's transl)].
    Rudy J; Sarosiek J; Borejszo I
    Przegl Lek; 1978; 35(12):879-83. PubMed ID: 734155
    [No Abstract]   [Full Text] [Related]  

  • 10. [Copper metabolism in rheumatoid arthritis and influence of D-penicillamine treatment].
    Crouzet J; Nafziger J; Guillien P; Camus JP; Lièvre JA
    Rev Rhum Mal Osteoartic; 1973; 40(7):485-9. PubMed ID: 4756424
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum levels of zinc and copper in rheumatoid arthritis].
    Mariani AM; Giordano N; Fioravanti A; Marcolongo R; Centini F; Comparini I; Leonzio C
    Boll Soc Ital Biol Sper; 1985 Aug; 61(8):1185-91. PubMed ID: 4063108
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic studies of D-penicillamine in the treatment of rheumatoid arthritis.
    Payne RW; Cahill CL
    J Okla State Med Assoc; 1969 Oct; 62(10):487-91. PubMed ID: 5406880
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of rheumatoid arthritis with D-penicillamine].
    Miehlke K
    Arzneimittelforschung; 1971 Nov; 21(11):1815-7. PubMed ID: 5171812
    [No Abstract]   [Full Text] [Related]  

  • 15. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?
    Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG
    J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bio-inorganic effects of D-penicillamine in children and in the elderly.
    Kean WF; Bellamy N; Lock CJ; Adachi J
    Clin Invest Med; 1984; 7(1):77-83. PubMed ID: 6723129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-Penicillamine. A contribution on the therapy of chronic progressive polyarthritis].
    Kohlhardt I; Miehlke K
    Med Welt; 1968 Apr; 17():1130-3. PubMed ID: 5727879
    [No Abstract]   [Full Text] [Related]  

  • 20. [The copper chelating effect of D-penicillamine in the long-term therapy of progressive chronic polyarthritis].
    Krüger HH
    Med Klin; 1970 Apr; 65(14):650-2. PubMed ID: 4994367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.